Tag: CBT > Cannabis Schedule: Page 4

Federal Cannabis Legalization

Cannabis Rescheduling: Where Do We Go From Here?

The legal team at Vicente addressed the significance of the potential move to reschedule cannabis, detailing the ramifications for state-legal cannabis businesses and what could happen next, during a webinar. Here are 12 key takeaways from the event.

May 10, 2024

Cannabis Rescheduling

Blumenauer Unveils Legislative Blueprint, Additional Administrative Action Needed Following Rescheduling

Congressman Earl Blumenauer, founder and co-chair of the Congressional Cannabis Caucus, demands Biden-Harris Administration use “every power available to them” to build on rescheduling.

May 7, 2024

Cannabis Rescheduling

Cannabis Rescheduling FAQ: What Now?

From potential timelines to 280E to SAFER Banking, legal experts explain the implications of the federal government reclassifying cannabis as a less dangerous substance.

May 6, 2024

Cannabis Rescheduling

Cannabis Rescheduling Reactions Mixed: While Some Applaud Potential, Others Push For More

Executives, lawmakers and nonprofit leaders weigh in on the significance and shortcomings of the DEA's move to reclassify cannabis as a less dangerous substance.

May 1, 2024

Cannabis Rescheduling

UPDATE: DEA Moves to Reschedule Cannabis

The federal agency that has long enforced prohibition aligns with the recommendation from the U.S. Department of Health and Human Services, FDA to reclassify cannabis as a Schedule III substance under the Controlled Substances Act.

April 30, 2024

Cannabis Rescheduling

21 US Lawmakers Express Frustration With DEA’s Inaction on Cannabis Rescheduling

The 11 senators and 10 House representatives urged for swift action to remove cannabis from a Schedule I listing in a new letter.

April 25, 2024

Legislation and Regulation

Federal Cannabis Legalization and Reform: Where Are We in 2024?

U.S. cannabis reform hasn’t come easy amid a divided Congress, but plenty of opportunities remain on the table for the remainder of the year.

April 20, 2024

Cannabis Rescheduling

3 GOP Senators Tell DEA Not to Reschedule Cannabis

Led by former presidential candidate Mitt Romney, the senators argue rescheduling would violate an international treaty in letter to DEA administrator.

March 27, 2024

Cannabis Rescheduling

Is Cannabis in Schedule I or V? HHS Secretary Forgets

U.S. Health Secretary Xavier Becerra couldn’t remember the plant’s classification during a subcommittee hearing on his department’s budget request, during which a dispute over HHS’ rescheduling recommendation arose.

March 20, 2024

Cannabis Rescheduling

DEA’s 5-Factor Test Makes Rescheduling Cannabis Impossible

After HHS used its own two-part test to determine the plant’s ‘currently accepted medical use,’ rescheduling opponents urge DEA to keep its five-part test.

March 19, 2024

Federal Cannabis Legalization

36 US House Democrats Urge Biden to Grant Cannabis Clemency For Thousands

Congressional Cannabis Caucus co-chairs Barbara Lee and Earl Blumenauer spearheaded a letter asking for those currently incarcerated to be released.

March 14, 2024

Cannabis Business Financial Report

Trulieve Reports Receiving Refund For 280E Taxes Paid

The multistate cannabis company, as noted in its 2023 financial report and earnings call, says it received $113 million of the more than $174 million it requested in combined amended state and federal tax returns.

February 29, 2024